- ATOS -1.52%
Atossa Genetics Inc. (ATOS) is a Great Momentum Stock: Should You Buy?
Yahoo Finance · 1 week ago
Search results
Atossa Therapeutics is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology. Atossa’s current focus is on breast cancer.
- 1.3000Add to watchlist-0.0200 (-1.52%)At close:4:00 PM EDTThu. May 30, 20241.3200 +0.02 (+1.54%)After hrs:6:35 PM EDTThu. May 30, 2024Nasdaq Real Time Price (USD) · Market closed
- Open1.3400High1.3400Low1.2900
- Mkt Cap163.48MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close1.320052 Wk. Low0.620052 Wk. High2.3100
Top storiesRelated stocks
Atossa ( Old Persian: Utauθa, or Old Iranian: Hutauθa; 550–475 BC) was an Achaemenid empress. She was the daughter of Cyrus the Great, and the wife of Darius the Great .
Find the latest Atossa Therapeutics, Inc. (ATOS) stock quote, history, news and other vital information to help you with your stock trading and investing.
May 15, 2024 · April 1, 2024. Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update. Fully enrolled two Phase 2 studies with data from both expected in the second half of 2024 First patient dosed in new Phase 2 breast cancer prevention study Data from ongoing Phase 2 EVANGELINE study scheduled to be presented at 2024 AACR ...
Atossa Therapeutics Provides Five-Year (Z)-Endoxifen Treatment Update on FDA-Approved "Expanded Access" Program for a U.S. Breast Cancer Patient. SEATTLE, March 19, 2024 (GLOBE NEWSWIRE) --...
Oct 15, 2023 · Queen Atossa was a force to reckon with in the Achaemenid Empire. As strategic leader, and mother to a future emperor, her impact echoes through time. The famed Achaemenid Empire was an ancient Iranian empire that was founded by the renowned Cyrus the Great in 550 BC.
Feb 22, 2024 · SEATTLE, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address...
